查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1470966

靜脈液市場：按類型、成分、最終用戶分類 - 全球預測 2024-2030

Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element), End-users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年靜脈輸液市場規模為137.6億美元，預計2024年將達149.9億美元，2030年將達253.8億美元，複合年成長率為9.13%。

靜脈輸液是設計用於經由靜脈導管直接注射病人靜脈循環的無菌液體，通常用於補水、矯正電解質失衡、給藥和輸血。靜脈輸液的成分根據預期目的而有很大差異，包括等滲透壓、高滲透壓和低滲透壓溶液，每種溶液都是為了實現特定的治療目標而客製化的。主要成分通常包括生理食鹽水、葡萄糖、電解質，有時還包括維生素和藥物。仔細選擇和管理靜脈輸液對於急性和慢性醫療機構的患者照護至關重要。了解靜脈輸液的正確處方和正確使用對於確保有效的治療結果和病人安全至關重要。靜脈輸液市場的推動因素包括慢性病盛行率的不斷上升、手術數量的增加以及全球靜脈製劑監管機構批准的增加。然而，靜脈輸液的技術限制和對熟練人員的需求對其採用提出了挑戰。提高靜脈輸液效率和安全性的進步和研究舉措為靜脈輸液市場的擴張提供了利潤豐厚的成長機會。

主要市場統計
基準年[2023] 137.6億美元
預測年份 [2024] 149.9億美元
預測年份 [2030] 253.8億美元
複合年成長率（%） 9.13%

由於營養和代謝需求的增加，全身腸外營養的使用正在擴大。

週邊腸外營養（PPN）透過週邊靜脈施用，通常用於需要短期營養支持或營養需求適中的患者。 PPN 的溶液濃度比 TPN 低，通常在必須避免留置中央靜脈導管引起併發症的風險時使用。 PPN 溶液通常是溶解在無菌水中的蛋白質、碳水化合物、維生素和礦物質。確切的成分根據患者的營養需求、醫療狀況、體重和液體耐受性進行調整。通常含有脂肪以提供必需脂肪酸和熱量。全身腸外營養（TPN）直接注射到中央靜脈系統，允許施用高濃度的營養物質。此方法適用於營養需求高的患者、有胃腸道併發症的患者、需要長期營養支持的患者。 TPN 可以完全繞過消化器官系統，將您所需的所有營養物質（包括碳水化合物、蛋白質、脂肪、維生素和礦物質）直接輸送到您的血液中。

最終用戶醫院和診所不斷成長的需求滿足了廣泛的患者需求

在門診手術中心，靜脈輸液對於控制手術過程中的水合和穩定性至關重要，它們還可以作為藥物給藥的載體，包括麻醉劑和鎮靜劑，在可能的情況下提供必要的營養支持。在醫院和診所等各種醫療保健環境中，靜脈輸液對於各種應用至關重要，從創傷或休克情況下的緊急液體復甦到專業部門的輸血和化療的藥物管理。靜脈輸液對於靜脈輸液管理水合和穩定性至關重要，在支持慢性病患者和老年患者的長期照護環境中也同樣重要，因為在這些環境中，水合、藥物管理和口服攝取有利於患者的腸外營養。專科診所利用靜脈注射解決方案進行特定治療，例如透析中的電解質平衡、疼痛管理以及荷爾蒙替代等標靶治療，以提供精確和受控的護理。

區域洞察

由於先進的醫療設施和行業領先的公司的存在，以美國為首的美國靜脈輸液市場正在擴大。需求顯著激增是由於癌症、糖尿病和胃腸道疾病等慢性疾病的增加。美洲地區專注於研發，促進創新產品的推出。在可支配收入增加、醫療保健框架擴大和健康意識不斷增強的推動下，亞太地區市場預計將出現快速成長，尤其是在中國和印度等成長中的經濟體。在政府改善醫療基礎設施和實施市場友善政策的支持下，亞太地區龐大的人口也為靜脈輸液市場的擴張提供了巨大的機會。歐洲、中東和非洲地區保持穩定成長，歐洲擁有完善的醫療保健系統、高度的病患意識和嚴格的監管標準。預計中東和非洲地區將出現溫和成長，這主要是由於波灣合作理事會（GCC）國家和南非活性化的醫療基礎設施投資以及對醫療服務的需求不斷成長。

FPNV定位矩陣

FPNV定位矩陣對於評估靜脈輸液市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對靜脈液市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.靜脈輸液市場規模及預測如何？

2.靜脈液市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3. 靜脈輸液市場的技術趨勢和法規結構是什麼？

4.靜脈輸液市場主要供應商的市場佔有率為何？

5.進入靜脈輸液市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 胃腸道疾病、癌症和神經系統疾病等慢性和急性疾病的發生率增加
      • 增加靜脈輸液的監管核准
      • 加強製造商之間的策略合作以增強產品系列
    • 抑制因素
      • 流體維護成本高
    • 機會
      • 新興經濟體對靜脈輸液的需求增加
      • 為患者提供便利的產品改進和新創新
      • 維生素C滴注在結直腸癌患者的實施
    • 任務
      • 靜脈輸液的副作用
  • 市場區隔分析
    • 類型：不斷成長的營養和代謝需求擴大了全腸外營養的使用
    • 最終使用者：醫院和診所的需求不斷增加，以滿足廣大病患的需求
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 靜脈液市場：依類型

  • 週邊腸外營養
  • 全腸外營養

第7章 靜脈液體市場構成方案

  • 碳水化合物
  • 聚葡萄糖
  • 肝素和微量元素
  • 腸外脂肪乳劑
  • 單劑量氨基酸溶液
  • 維生素和礦物質

第8章靜脈液體市場：依最終使用者分類

  • 門診手術中心
  • 醫院/診所
  • 長期照護設施
  • 專科診所

第9章 北美、南美靜脈輸液市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太靜脈液體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲靜脈注射液市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Hikma 宣佈在美國發布 COMBOGESIC IV
    • Sanjivani Palantral Limited 與 HAL 合作生產靜脈注射製劑和靜脈注射套件
    • CTMUHB 和 Baxter 合作實現更安全的靜脈輸液
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-710B1F0AC675

[194 Pages Report] The Intravenous Solutions Market size was estimated at USD 13.76 billion in 2023 and expected to reach USD 14.99 billion in 2024, at a CAGR 9.13% to reach USD 25.38 billion by 2030.

Intravenous solutions are sterile liquids designed to be administered directly into the venous circulation of a patient via an IV catheter and are commonly used for fluid replacement, correcting electrolyte imbalances, delivering medications, and blood transfusions. The composition of intravenous solutions can vary widely depending on their intended purpose, including isotonic, hypertonic, and hypotonic solutions, each tailored to achieve specific therapeutic objectives. Key constituents often include saline, dextrose, electrolytes, and sometimes vitamins or medications. Careful selection and administration of Intravenous solutions are critical for patient care in acute and chronic medical settings. Understanding the precise formulation and appropriate use of intravenous solutions is foundational to ensuring effective treatment outcomes and patient safety. The intravenous solutions market is driven by an increasing prevalence of chronic diseases, rising incidences of surgeries, and rising regulatory approvals for intravenous formulations globally. However, technical limitations of intravenous solutions and the need for skilled personnel pose a challenge to adopting intravenous solutions. Advancements and research initiatives to improve the efficiency and safety of intravenous fluids are offering lucrative growth opportunities for the Intravenous solutions market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 13.76 billion
Estimated Year [2024] USD 14.99 billion
Forecast Year [2030] USD 25.38 billion
CAGR (%) 9.13%

Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs

Peripheral parenteral nutrition (PPN) is administered through a peripheral vein, typically for patients requiring nutritional support for a short period or when the nutritional requirement is not very high. PPN is a less concentrated solution than TPN and is often used when the risk of complications from central venous catheterization must be avoided. PPN solutions generally contain proteins, carbohydrates, vitamins, and minerals dissolved in sterile water. The precise composition is adjusted based on the nutritional needs of patients, medical conditions, body weight, and fluid tolerance. Lipids are often included to provide essential fatty acids and calories. Total parenteral nutrition (TPN) is delivered directly into the central venous system, allowing for a higher concentration of nutrients to be administered. This method is suitable for patients with significant nutritional needs, gastrointestinal complications, and for those who require long-term nutritional support. TPN can completely bypass the digestive system, directly providing all necessary nutrients such as carbohydrates, proteins, fats, vitamins, and minerals into the bloodstream.

End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs

In ambulatory surgical centers, intravenous solutions are indispensable for fluid replacement to manage hydration and stability during surgeries and also function as vehicles for medication administration, including anesthetics and sedatives, and provide essential nutritional support when oral intake is not feasible. In more extensive healthcare settings, such as hospitals and clinics, IV solutions are vital for various uses, from emergency fluid resuscitation in trauma or shock cases, and medication delivery to blood transfusions and chemotherapy in specialized departments. Intravenous solutions are indispensable for fluid replacement to manage hydration and stability du are equally crucial in long-term care settings for the support of chronically ill or elderly patients, facilitating hydration, medication management, and parenteral nutrition for those unable to consume food orally. Specialty clinics harness IV solutions for specific treatments such as electrolyte balancing in dialysis, pain management, and targeted therapies such as hormone replacements, ensuring precise and controlled care delivery.

Regional Insights

In the Americas, the intravenous solutions market is expanding, with the United States at the forefront due to its advanced healthcare facilities and the presence of leading industry players. A notable demand surge is attributed to the rising cases of chronic diseases such as cancer, diabetes, and gastrointestinal disorders. The Americas benefits from a strong focus on research and development, fostering the introduction of innovative products. The Asia-Pacific region is poised for the fastest market growth, propelled by increasing disposable incomes, expanding healthcare framework, and heightened health awareness, particularly in growing economies such as China and India. The extensive population in the Asia-Pacific region also offers vast opportunities for the intravenous solutions market expansion, supported by government efforts to improve healthcare infrastructure and implement market-friendly policies. The EMEA region maintains steady growth, with Europe having sophisticated healthcare systems, high levels of patient awareness, and stringent regulatory standards. The Middle East and Africa are projected to witness moderate growth, primarily driven by heightened healthcare infrastructure investments and a growing demand for healthcare services in Gulf Cooperation Council (GCC) countries and South Africa.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intravenous Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intravenous Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Solutions Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amanta Healthcare Ltd., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Enzymes Pharmaceuticals, Eurolife Healthcare Pvt. Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., ICU Medical, Inc., JW Life Science Corporation, Lxir Medilabs Pvt. Ltd., Nymak Pharma Ltd., Otsuka Holdings Co., Ltd., Pfizer Inc., Salius Pharma Private Limited, Schwitz Biotech, Sichuan Kelun Pharmaceutical Co., Ltd., Soxa Formulations & Research Pvt. Ltd., Terumo Corporation, Trumac Healthcare, Varni Corporation, and Vifor Pharma Management Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Peripheral Parenteral Nutrition
    • Total Parenteral Nutrition
  • Composition Solution
    • Carbohydrates
    • Dextran
    • Heparin & Trace Element
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solution
    • Vitamins & Minerals
  • End-users
    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Long-term Care Facilities
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intravenous Solutions Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intravenous Solutions Market?

3. What are the technology trends and regulatory frameworks in the Intravenous Solutions Market?

4. What is the market share of the leading vendors in the Intravenous Solutions Market?

5. Which modes and strategic moves are suitable for entering the Intravenous Solutions Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
      • 5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
      • 5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Maintenance of Fluids
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
      • 5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
      • 5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects of Intravenous Fluids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
    • 5.2.2. End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Intravenous Solutions Market, by Type

  • 6.1. Introduction
  • 6.2. Peripheral Parenteral Nutrition
  • 6.3. Total Parenteral Nutrition

7. Intravenous Solutions Market, by Composition Solution

  • 7.1. Introduction
  • 7.2. Carbohydrates
  • 7.3. Dextran
  • 7.4. Heparin & Trace Element
  • 7.5. Parenteral Lipid Emulsion
  • 7.6. Single Dose Amino Acid Solution
  • 7.7. Vitamins & Minerals

8. Intravenous Solutions Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Long-term Care Facilities
  • 8.5. Specialty Clinics

9. Americas Intravenous Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intravenous Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intravenous Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Hikma announces US launch of COMBOGESIC IV
    • 12.3.2. Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets
    • 12.3.3. CTMUHB and Baxter partner to implement safer IV fluid administration
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
  • FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 291. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023